The Role of Glucagon in the Endogenous Hyperglycemia of Diabetes Mellitus
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Recent advances in our understanding of the glucagon-secreting pancreatic a cell as a vital component of the functional machinery of the primary fuel-regulating organ, the islets of Langerhans, have made possible new insights into its physiology and pathophysiology. It has recently been proposed that glucagon, or closely related polypeptides with biologic actions similar to those of glucagon, plays an essential role in the development of the full diabetic syndrome, specifically, endogenous hyperglycemia ( 1, 2) and hyperketonemia (2, 3). If this is true, a safe and practical means of glucagon suppression might have therapeutic potential in improving the currently unsatisfactory methods of controlling diabetic hyperglycemia. The pur pose of this review is to consider briefly the evidence that assigns to glucagon a vital role in the maintenance of euglycemia in nondiabetics and a deleterious role in certain of the metabolic abnormalities of diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Studies of pancreatic alpha cell function in normal and diabetic subjects
Unger, R. H., Aguilar-Parada, E., Müller, W. A., & Eisentraut, A. M. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106297 · Cited by 837
Self-citationGerich, J. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1973) · Science · doi:10.1126/science.182.4108.171 · Cited by 688
Abnormal Alpha-Cell Function in Diabetes: Response to Carbohydrate and Protein Ingestion
Müller, W. A., Faloona, G. R., Aguilar-Parada, E., & Unger, R. H. (1970) · New England Journal of Medicine · doi:10.1056/nejm197007162830301 · Cited by 626
Self-citationThe essential role of glucagon in the pathogenesis of diabetes mellitus
Unger, R., & Orci, L. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92375-2 · Cited by 599
Self-citationThe Banting Memorial Lecture 1975: Diabetes and the Alpha Cell
Unger, R. H. (1976) · Diabetes · doi:10.2337/diab.25.2.136 · Cited by 234
Self-citationGerich, J. E., Lorenzi, M., Bier, D. M., Tsalikian, E., Schneider, V, Karam, J. H., & Forsham, P. H. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108364 · Cited by 198
ABNORMALITIES OF GLUCAGON METABOLISM IN UNTREATED DIABETES MELLITUS
Buchanan, K. D., & Mccarroll, A. M. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92964-9 · Cited by 97
Cited by
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Kawamori, D., Kurpad, A. J., Hu, J., Liew, C. W., Shih, J. L., Ford, E. L., Herrera, P. L., Polonsky, K. S., McGuinness, O. P., & Kulkarni, R. N. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.007 · Cited by 316
Paracrine regulation of glucagon secretion: the β/α/δ model
Watts, M., Ha, J., Kimchi, O., & Sherman, A. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00415.2015 · Cited by 53
GLP-1-Based Strategies: A Physiological Analysis of Differential Mode of Action
Burcelin, R., Gourdy, P., & Dalle, S. (2014) · Physiology · doi:10.1152/physiol.00009.2013 · Cited by 26
Pramlintide: Clinical Strategies for Success
Alrefai, H. A., Latif, K. A., Hieronymus, L. B., Weakley, C. R., & Moss, R. J. (2010) · Diabetes Spectrum · doi:10.2337/diaspect.23.2.124 · Cited by 16
Metadata
- Authors
- Unger, R. H.
- Venue
- Annual Review of Medicine
- Publisher
- Annual Reviews
- Published
- 1977-02
- Volume
- 28
- Issue
- 1
- Pages
- 119-130
- ISSN
- 0066-4219 (ISSN-L)
- 1545-326X
- OpenAlex
- W2096357593
- Cited by
- 46
- References
- 7
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of Glucagon in the Endogenous Hyperglycemia of Diabetes Mellitus. https://app.cochat.ai/papers/10.1146/annurev.me.28.020177.001003
- The paper
- Unger, R. H. (1977). The Role of Glucagon in the Endogenous Hyperglycemia of Diabetes Mellitus. Annual Review of Medicine. https://doi.org/10.1146/annurev.me.28.020177.001003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.